Since 2008, we have been a subsidiary of
FAREVA Group, which operates in 13 countries and has 41 production sites and 16 research and development centers around the world.
Our key focus is on developing and manufacturing products for cancer treatment and immunosuppressive therapies.
Developing and manufacturing products from tablets and capsules up to final packaging.
We are specialized in high containment solutions. Our experience includes:
Developing and manufacturing highly potent APIs at level OEB 4 to OEB 6
We work with big pharma, medium-sized companies, start-ups and virtual companies. Our goal is to build long-term partnerships with our customers and suppliers.
Norbert Straub, R&D Director Pharma Highly Potent
We are your partner, not your competitor.
Dr. Angrit Trapp, Director Customer Relations
We offer complete development
– including scale-up and one-to-one transfer of the manufacturing process –
all the way through to commercial manufacturing.
This is by no means standard for a company of our size.
But we have what it takes: Our employees are extremely well trained,
our analytics department is perfectly equipped and our facilities are
versatile to handle both clinical and commercial programs.
Apart from our services, we also offer a portfolio
of around 30 active ingredients for the generics market.
We strive to meet our customer’s expectations.
Dr. Georg Straller, Abteilungsleiter Entwicklung und Transfer, Pharma
We offer extensive support for global regulatory approvals of active pharmaceutical ingredients.
Dr. Christine Sonner, Director Quality Management
We offer extensive support for global regulatory approvals of active pharmaceutical ingredients.
Nils Wendland, Regulatory Affairs
• Germany: Government of Upper Franconia, last inspection: May 2018, pharmaceutical ingredients May 2022
• USA: FDA, last inspection: July 2019
• Russia: State Institute of Drugs and Good Practices, last inspection: February 2022
• Brazil: ANVISA, last inspection: June 2018
• Korea: Ministry of Food and Drug Safety, last inspection: 2016
• Turkey: last inspection 2018
We have clients in USA, Japan, Europe, Russia,
Korea, China, Brazil, Australia, New Zealand, Taiwan, Africa…
We adapt to the most diverse mentalities – and enjoy it.
Employee safety is our top priority. Always and without exception. Additionally, environmental protection is fundamental focus area for the site. For example, we base our work on HAZOP.
Our employees are well trained and our facilities are fully equipped – from sophisticated building automation to dust extractors, waste air scrubbers and much more.
Daniela Kovats, Manager EHS
Our team is made up of chemical technicians, chemical laboratory assistants, pharmaceutical technicians, pharmacists, chemists and chemical engineers. We have extensive expertise and a wealth of experience in process and analytical development and manufacturing.
This experience allows us to make valuable recommendations during the project and to get results quickly.
We support our three
production teams, primarily
with on-time analytics.
We continuously adapt our analytical skills, technical expertise and quality standards to your requirements.
We deliver the complete process from development through production to packaging of your medicines.